"Analgesics in Colombia" Published

From: Fast Market Research, Inc.
Published: Fri Apr 03 2015


With almost a third of total OTC sales in Colombia, analgesics was the most important individual category in terms of value in the market in 2014. Pain alleviation is a major health concern not only in over-the-counter sales, but also in Rx. According to trade sources, pain is the most common symptom that adversely impacts the quality of life, and causing mild to severe levels of disability. For this consumers seek fast and long-lasting analgesics in a category where emotions play a critical role on product choice. The emotional effects of pain can affect the decision-making process of consumers, and manufacturers and pharmacists play a fundamental role in setting easy-to-follow guidelines to attain an adequate self-medication approach.

Competitive Landscape

GlaxoSmithKline Colombia SA continues to be the leader in analgesics with Dolex, the most renowned analgesics brand in Colombia. The company accomplished a successful brand extension and image revamping over the review period, leveraging is recognition and to guarantee rising sales. Currently there are many options for Dolex including the leading paediatric analgesics brand, Dolex Niņos (Children), Dolex Ultra, Dolex Avanzado (Advanced) among others. The brand also has a significant share in the cough, cold and allergy (hay fever) remedies. Advil is the second most important brand, owned by Pfizer Colombia SA.

Full Report Details at
- http://www.fastmr.com/prod/972485_analgesics_in_colombia.aspx?afid=302

Industry Prospects

Despite being a mature category, analgesics is likely to continue growing thanks to intense promotion of newer pharmaceutical forms for fast and long-acting effects, such as soft gel capsules and the fast absorbing formulation of Dolex Avanzado in coated tablets for gastric protection, as well as other key drivers. Pain prevalence is not likely to grow dramatically but pain perception will continue evolving over the forecast period. Consumers will have more alternatives to deal with several types of pain. Along with natural pain causes such as menstrual pain, with regard to which analgesics are likely to remain stable, alleviation of pain associated with a more agitated way of life and poor posture due sedentary lifestyles will continue to be crucial in this highly competitive category. Increased consumption will bring challenges related to achieving responsible self-medication to meet an adequate self-care approach. Manufacturers and a proper counselling of healthcare providers or pharmacists can play a fundamental role in encouraging chronic analgesic consumers to look for subjacent causes of pain and to be more aware and monitor likely effects of long-lasting consumption. Remembering that pain is mostly a symptom and not a disease per se will be important in the messages delivered to consumers.

Report Overview

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in Estonia
- Vitamin and Provitamin Market in Colombia to 2018 - Market Size, Trends, and Forecasts
- Medical Device Market in Colombia to 2018 - Market Size, Trends, and Forecasts
- Sports Good Market in Colombia to 2019 - Market Size, Trends, and Forecasts
- Construction and Mining Machinery Market in Colombia to 2018 - Market Size, Trends, and Forecasts

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »